logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
PrescriberPoint
HIPPA Logo
HIPPA COMPLIANT
HIPPA Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.

    • Vitruvias Therapeutics drugs

    FiltersReset Filters
    6 results

    • aminocaproic acid - aminocaproic acid solution

      (Aminocaproic Acid)
      Vitruvias Therapeutics

    • aminocaproic acid - aminocaproic acid tablet

      (Aminocaproic Acid)
      Vitruvias Therapeutics

    • bupropion hydrochloride

      (Bupropion hydrochloride)
      Vitruvias Therapeutics
      Usage: Bupropion hydrochloride extended-release tablets are indicated for the treatment of major depressive disorder (MDD) and the prevention of seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy was established through controlled trials for both conditions.

    • bupropion hydrochloride

      (Bupropion Hydrochloride)
      Vitruvias Therapeutics

    • cyanocobalamin - cyanocobalamin injection, solution

      (Cyanocobalamin)
      Vitruvias Therapeutics

    • propafenone hydrochloride

      (propafenone)
      Vitruvias Therapeutics
      Usage: Propafenone hydrochloride extended-release capsules are indicated for prolonging the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic AF who lack structural heart disease. Its use is not established for permanent AF or atrial flutter, nor for controlling ventricular rate during AF.